Table 1. Correlation between SFRP2 expression and clinicopathological characteristics of glioma patients.
Characteristics | n | SFRP2 expression | P value | |
---|---|---|---|---|
Low | High | |||
Age (Years) | 0.298 | |||
≤60 | 59 | 25 | 34 | |
>60 | 107 | 61 | 46 | |
Sex | 0.685 | |||
Male | 71 | 35 | 36 | |
Female | 95 | 51 | 44 | |
Tumor size (mm) | 0.025 | |||
≥ 30 | 105 | 71 | 34 | |
<30 | 61 | 15 | 46 | |
WHO grade | 0.001 | |||
II | 45 | 10 | 35 | |
III | 60 | 29 | 31 | |
IV | 61 | 47 | 14 | |
Treatment | 0.035 | |||
Radiotherapy | 78 | 53 | 25 | |
Non-Radiotherapy | 88 | 33 | 55 | |
Radiotherapy response | 0.001 | |||
Sensitive | 29 | 12 | 17 | |
Resistant | 49 | 41 | 8 |